Improve data management to improve endpoint adjudication success in clinical trials

In the winter issue of International Clinical Trials, CEO Abraham Gutman writes about how poor management of data is one of the factors ailing adverse event and endpoint adjudication in clinical trials. The clinical trial industry is transforming, and the vision for this is simple: embrace quality and automation across the clinical trial spectrum and […]

Read More...

Unique Needs for Medical Device Clinical Trials

AG Mednet’s Brian Kelly joins experts from Oracle to address data quality and compliance in medical device trials during this upcoming webcast. The webcast – Adaptive Medical Device Trials for Fast, Seamless and Accurate Research – takes place Thursday, January 25, 2018, noon EST. Medical device studies are complex and unique, with evolving regulatory oversight […]

Read More...

Learn About AG Mednet’s Endpoint Adjudication Technology at Leading Clinical Trial Events This Fall

BOSTON – October 27, 2017 – As part of its mission to move the clinical trial industry even closer to the goal of zero-delay clinical trials, AG Mednet will both attend and exhibit at several key industry events this fall. A leader in clinical trial technology innovation, AG Mednet is reimagining how endpoint adjudication can […]

Read More...

AG Mednet Launches Endpoint Adjudication Technology to Ensure Data Quality

Judi helps sponsors and CROs manage clinical events from trigger to final adjudication   Boston, MA – May 2, 2017 – AG Mednet continues its drive to advance clinical trials with the launch of Judi, the first comprehensive electronic endpoint adjudication system to manage workflow and ensure data quality. Judi helps sponsors and CROs manage […]

Read More...

FDA draft guidance and clinical trials

In 2015, the Food and Drug Administration released the Clinical Trial Imaging Endpoint Process Standards draft guidance for the clinical trial industry. According to the FDA, the purpose of the guidance is to assist sponsors in optimizing the quality of imaging data obtained in clinical trials intended to support approval of drugs and biological products. More specifically, […]

Read More...